封面
市场调查报告书
商品编码
1748750

合约研究组织市场-全球产业规模、份额、趋势、机会和预测(按服务、应用、地区和竞争细分,2020-2030 年预测)

Contract Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Application, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球合约研究组织 (CRO) 市场价值为 521.5 亿美元,预计到 2030 年将达到 681.5 亿美元,复合年增长率为 4.76%。药物开发日益复杂的过程、高成本以及严格的监管审查是推动市场成长的关键因素。製药和生技公司面临越来越大的压力,需要在遵守全球监管架构的同时,加速开发进度、控制开支。为了实现这一目标,许多公司将临床和临床前研究职能外包给 CRO,后者提供专业知识、全球基础设施和尖端技术。 CRO 在简化开发工作流程、管理合规性和实现研究工作的可扩展性方面发挥关键作用。然而,竞争压力、跨地区不断变化的监管环境以及对严格的资料完整性和良好临床实践 (GCP) 合规性的需求阻碍了市场成长。儘管面临这些挑战,CRO 仍然是在日益全球化的製药领域提供经济高效的研究服务的策略合作伙伴。

市场概览
预测期 2026-2030
2024年市场规模 521.5亿美元
2030年市场规模 681.5亿美元
2025-2030 年复合年增长率 4.76%
成长最快的领域 早期开发服务
最大的市场 北美洲

关键市场驱动因素

医疗保健产业的成长

主要市场挑战

临床试验成本上升

主要市场趋势

生物相似药和生物製剂试验的增加

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:COVID-19 对全球合约研究组织市场的影响

第五章:全球合约研究组织市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按服务(早期开发服务、临床研究服务、实验室服务、咨询服务、资料管理服务)
    • 依应用(肿瘤学、中枢神经系统、心血管、呼吸系统、传染病、自体免疫疾病、其他)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美合约研究组织市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章:欧洲合约研究组织市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太地区合约研究组织市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章:南美洲合约研究组织市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东和非洲合约研究组织市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 合併与收购(如有)
  • 产品发布(如有)
  • 最新动态

第十三章:干扰:衝突、流行病与贸易壁垒

第 14 章:全球合约研究组织市场:SWOT 分析

第 15 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 16 章:竞争格局

  • GE HealthCare Technologies Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • PerkinElmer Inc.
  • Standard BioTools Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen NV

第 17 章:策略建议

第18章调查会社について・免责事项

简介目录
Product Code: 7311

The Global Contract Research Organization Market was valued at USD 52.15 Billion in 2024 and is projected to reach USD 68.15 Billion by 2030, growing at a CAGR of 4.76%. The increasing complexity, cost, and regulatory scrutiny associated with drug development are key factors fueling the market's growth. Pharmaceutical and biotechnology companies are facing mounting pressure to accelerate development timelines and manage expenses while complying with global regulatory frameworks. To achieve this, many are outsourcing clinical and preclinical research functions to CROs, which offer specialized expertise, global infrastructure, and cutting-edge technologies. CROs play a pivotal role in streamlining development workflows, managing compliance, and enabling scalability in research efforts. However, market growth is tempered by competitive pressures, evolving regulatory landscapes across regions, and the need for stringent data integrity and Good Clinical Practice (GCP) compliance. Despite these challenges, CROs continue to be strategic partners in delivering cost-effective and efficient research services across an increasingly globalized pharmaceutical landscape.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 52.15 Billion
Market Size 2030USD 68.15 Billion
CAGR 2025-20304.76%
Fastest Growing SegmentEarly Phase Development Services
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The rapid expansion of the global healthcare industry is a major driver of the Contract Research Organization market. Rising investments in biopharmaceutical R&D, increasing focus on personalized medicine, and an expanding portfolio of therapeutic innovations are prompting pharmaceutical and medical device companies to seek external support from CROs. Countries such as Finland, Belgium, and Japan are leading with highly efficient healthcare systems, while even advanced markets like the U.S. face ongoing challenges in cost and care accessibility. With millions remaining uninsured and healthcare systems under pressure, pharmaceutical companies are leveraging CROs to improve efficiency and minimize development risks. CROs offer a range of services-spanning early-stage discovery to post-market surveillance-that help sponsors navigate complex clinical and regulatory environments. As healthcare demands rise, so does the need for efficient outsourcing solutions that CROs are well-positioned to provide.

Key Market Challenges

Rising Cost of Clinical Trials

Escalating costs associated with conducting clinical trials present a significant challenge for the CRO industry. As trial protocols become more complex, involving diverse geographies, larger patient populations, and advanced data requirements, the financial burden on sponsors and service providers increases. Additional costs stem from the integration of high-end technologies, including biomarker analysis, genomic profiling, and real-time data monitoring tools-all of which require significant investment in infrastructure and expertise. Logistical complexities associated with managing global trial sites and ensuring regulatory compliance across jurisdictions add further operational strain. For CROs, balancing cost-efficiency with quality service delivery remains a critical concern, particularly when servicing cost-sensitive clients or navigating budget constraints in emerging markets.

Key Market Trends

Rise in Biosimilars and Biologics Trials

The expanding focus on biosimilars and biologics is reshaping the global CRO landscape. The expiration of patents on high-value biologic drugs has opened opportunities for biosimilar development, especially in markets like India that offer cost-effective research ecosystems and supportive regulatory structures. India is increasingly recognized as a preferred location for biosimilar trials due to its skilled workforce and favorable clinical infrastructure. Meanwhile, the rise of complex biologics-including monoclonal antibodies, vaccines, and gene therapies-requires specialized research capabilities. CROs equipped to handle bioanalytical testing, immunogenicity evaluation, and biomarker analysis are in high demand as sponsors look for end-to-end biologics expertise. This trend reflects a broader shift toward advanced therapies and precision medicine, with CROs playing a vital role in accelerating development and navigating the regulatory complexities of modern biologics.

Key Market Players

  • GE HealthCare Technologies Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • PerkinElmer Inc.
  • Standard BioTools Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.

Report Scope

In this report, the Global Contract Research Organization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contract Research Organization Market, By Service:

  • Early Phase Development Services
  • Clinical Research Services
  • Laboratory Services
  • Consulting Services
  • Data Management Services

Contract Research Organization Market, By Application:

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Infectious Diseases
  • Autoimmune Disorders
  • Others

Contract Research Organization Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contract Research Organization Market.

Available Customizations

Global Contract Research Organization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Contract Research Organization Market

5. Global Contract Research Organization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Early Phase Development Services, Clinical Research Services, Laboratory Services, Consulting Services, Data Management Services)
    • 5.2.2. By Application (Oncology, Central Nervous System, Cardiovascular, Respiratory, Infectious Diseases, Autoimmune Disorders, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Contract Research Organization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Contract Research Organization Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Contract Research Organization Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Contract Research Organization Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Application

7. Europe Contract Research Organization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Contract Research Organization Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Contract Research Organization Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Contract Research Organization Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Contract Research Organization Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Contract Research Organization Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Application

8. Asia Pacific Contract Research Organization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Contract Research Organization Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Application
    • 8.3.2. India Contract Research Organization Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Contract Research Organization Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Contract Research Organization Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Contract Research Organization Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Application

9. South America Contract Research Organization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Contract Research Organization Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Contract Research Organization Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Contract Research Organization Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Application

10. Middle East and Africa Contract Research Organization Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Contract Research Organization Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Contract Research Organization Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Contract Research Organization Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Contract Research Organization Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. GE HealthCare Technologies Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Abbott Laboratories
  • 16.3. Agilent Technologies, Inc.
  • 16.4. PerkinElmer Inc.
  • 16.5. Standard BioTools Inc.
  • 16.6. Illumina, Inc.
  • 16.7. Bio-Rad Laboratories Inc.
  • 16.8. Cepheid Inc.
  • 16.9. Thermo Fisher Scientific, Inc.
  • 16.10. Qiagen N.V.

17. Strategic Recommendations

18. About Us & Disclaimer